

1,402,106 filings since 2004 · latest accepted Nov 4, 2026, 10:45 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Aug 12, 2026 accepted 10:59 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jun 25, 2026 accepted 8:30 PM ET | PLXProtalix BioTherapeutics, Inc. | 5.07Shareholder vote | Document |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
May 21, 2026 accepted 11:03 AM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
May 13, 2026 accepted 10:57 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Mar 18, 2026 accepted 10:56 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Mar 9, 2026 accepted 11:51 AM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Feb 11, 2026 accepted 10:10 PM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Jan 30, 2026 accepted 3:09 PM ET | PLXProtalix BioTherapeutics, Inc. | 8.01Other events | DocumentSEC ↗ |
Jan 5, 2026 accepted 11:56 AM ET | PLXProtalix BioTherapeutics, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Nov 13, 2025 accepted 11:54 AM ET | PLXProtalix BioTherapeutics, Inc. | 2.02Earnings release | DocumentSEC ↗ |